Ligand validation:2UXK

HTO: HEPTANE-1,2,3-TRIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2UXK_HTO_L_1291	10%	76%	0.266	0.773	0.33	0.61	-	-	0	0	100%	1
2WX5_HTO_M_1313	43%	40%	0.183	0.906	1.08	1.24	1	1	7	1	100%	1
1RG5_HTO_L_707	29%	44%	0.253	0.911	0.59	1.54	-	2	0	0	100%	0.5
1YF6_HTO_L_863	21%	26%	0.227	0.839	0.87	2.09	-	2	0	0	100%	1
6Z02_HTO_L_315	13%	60%	0.365	0.914	0.24	1.27	-	1	2	0	100%	1
4IN6_HTO_L_305	7%	28%	0.396	0.864	1.19	1.67	1	3	0	0	100%	1
2HPY_HTO_B_1401	79%	28%	0.103	0.95	1.81	1.1	2	1	1	0	100%	1
3G7F_HTO_H_705	67%	67%	0.131	0.94	0.41	0.84	-	-	1	0	100%	1
5IU8_HTO_A_2402	59%	12%	0.141	0.922	0.51	3.53	-	3	0	0	100%	1
3DTU_HTO_B_1	59%	73%	0.153	0.934	0.21	0.82	-	-	1	1	100%	1
4TSY_HTO_A_209	57%	40%	0.161	0.937	0.59	1.71	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.